what to know about compounded semaglutide Wegovy vs Semaglutide: Key Differences GLP-1 Compounded Semaglutide for Weight

Lebherz C, Kahles F, Piotrowski K et al (2016) Interleukin - 6 predicts inflammation - induced increase of glucagon - like peptide - 1 in humans in response to cardiac surgery with association to parameters of glucose metabolism

Most Common Adverse Events Key Observations: Gastrointestinal adverse events are dose-dependent and most pronounced during dose escalation Symptoms typically peak within the first 4-8 weeks and diminish with continued treatment as tolerance develops Slow titration (4-week intervals) significantly reduces the incidence and severity of GI events Most adverse events classified as mild to moderate in severity [9] Discontinuation Rates 7.3% Placebo discontinuation rate [9] 15.8% Cagrilintide 2.4 mg (optimal dose) [9] 24.5% Cagrilintide 4.5 mg (high dose) [9] The majority of discontinuations due to adverse events occurred during the titration phase, with GI symptoms (nausea, vomiting) being the primary reasons

Allow Materials to Reach Room Temperature If the peptide vial has been stored in the refrigerator or freezer, allow it to reach room temperature before opening

Legacy Personal Training proudly serves Desert Highlands and the North Scottsdale community